EnhancerAtlas 2.0: an updated resource with typical enhancer annotation in 600 tissue/cell types across nine species

TagContent
EnhancerAtlas ID
HS002-02667 
Organism
Homo sapiens 
Tissue/cell
A375 
Coordinate
chr12:109249390-109251200 
Target genes
Number: 6             
NameEnsembl ID
SNPs
Number: 1             
IDChromosomePositionGenome Version
rs987044chr12109250356hg19
Number of super-enhancer constituents: 35             
IDCoordinateTissue/cell
SE_00113chr12:109244424-109251439Adipose_Nuclei
SE_01037chr12:109249271-109251865Adrenal_Gland
SE_01623chr12:109246181-109252083Aorta
SE_02246chr12:109246168-109252078Astrocytes
SE_04650chr12:109249244-109251148Brain_Anterior_Caudate
SE_06218chr12:109246114-109251372Brain_Hippocampus_Middle
SE_08617chr12:109249226-109251457Brain_Inferior_Temporal_Lobe
SE_09493chr12:109247147-109253018CD14
SE_25830chr12:109244536-109251201Duodenum_Smooth_Muscle
SE_26704chr12:109246214-109251864Esophagus
SE_29719chr12:109249196-109251365Fetal_Muscle
SE_32104chr12:109249273-109251984Gastric
SE_34450chr12:109246280-109252128HCT-116
SE_34725chr12:109245953-109252240HeLa
SE_36100chr12:109246988-109251401HMEC
SE_36924chr12:109244176-109251762HSMMtube
SE_37947chr12:109244148-109252158HUVEC
SE_38903chr12:109246069-109251429IMR90
SE_40657chr12:109245919-109253030Left_Ventricle
SE_42149chr12:109245912-109252798Lung
SE_44139chr12:109246155-109251395NHDF-Ad
SE_44751chr12:109244532-109252762NHLF
SE_45545chr12:109244280-109252952Osteoblasts
SE_47346chr12:109244433-109251321Panc1
SE_48097chr12:109245995-109252101Psoas_Muscle
SE_48602chr12:109245944-109251883Right_Atrium
SE_49578chr12:109249348-109251413Right_Ventricle
SE_50432chr12:109246119-109251878Sigmoid_Colon
SE_51142chr12:109244391-109251449Skeletal_Muscle
SE_51706chr12:109246219-109251409Skeletal_Muscle_Myoblast
SE_52666chr12:109246054-109251874Small_Intestine
SE_53376chr12:109245391-109252770Spleen
SE_63492chr12:109246142-109251594HSMM
SE_65195chr12:109247561-109251325NHEK
SE_68566chr12:109231845-109256560TC71
Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder
Number of disease enhancers: 1             
ChromosomeStartEnd
chr12109250000109250362
Enhancer Sequence
CCAACCTCTC CCCTTACCTC ACATAAACTT TTGTGATGAG AACCTGAGAT TAAGTGCATA 60
AATTGCCAGA CAGCAGTGAC CGGAACAGAA AACAGCCCCT CCTCGCTGTG GGAAGGAAAG 120
GCGCTCCTGC AACCTAACTT CTCAGTAGCA GGCTATTGAT CGCCAGTGTT CTTTTGCCTC 180
TAATCAGCGT GTAGAGGGGG ATTACTAGAA CCTTCTGTGT ATAGATAACT CATGAATGGC 240
CTCTCCTCTC CAAGGAGGGG GCTGTGAAGG TTCAACTTCC CAGCCACTCT GAAAATGTCC 300
CTGCCAATCC CAGCAAAACA AGGCTGAAGA ACTACCCTAC CAGGAGACAG GGCTGTCAAG 360
CCAAATGCAA ACATTATTCT CTTGTCTCTC TCAGACACAC AAACCTCCCC CGTGTTATCA 420
GTCAACTTCC CCCACTCCCT CCCACAAAGA AAGGGGCTGA AGAGCCCAGA TGCTGGCTGC 480
GGAACTTCCT GGGCCTGGGA CCGCAGGGCC GCTCCTCCAG TCTTCTCTAA ACACAGCTAA 540
GGGTCTGCAG GCGGACACTC AGCCTTGTTA TAGGTAAGAG TTTAGACCAG AGGCCTTGAC 600
GGGTTCTTCA AGAGATGGTG GGCAAGATTG CGCGACCAGA GGGTCATCCC TGCAGCTACA 660
GAGGGCTGAC CTGCTCAGAG GCCCAAGGCC CCAGCCTAGG ACAAGCCAGG CCAACCCTGC 720
AGGCTAAGAG GGCAACAGTG CCCTCAATCA ACCCCAGAGG AAAAAGTGGC CAGGCAAACG 780
GACCTGGGCC ACACACAGAC CCACAAAAAC GCGCACAGTG CCAGGACACG CAACCCAGGA 840
ATGCACCTAT GCAATCACCC AGAATGGGTC ACAGCCACAC AGAAAGATAG ATGCACATAA 900
ACACACAGGC CTGAGTGATG TTACAGAAAG GAAAAGCCAG ACTAAGGCTG CACGCACAGA 960
CGTGAAACAC AGCCACACAG AGCCCACAGC ACGCTCGGTC ACCGTCACAC AGTGACACGG 1020
GCACGCCTAC AGACAGAACT CCAGAGGCGG CAGGCGGGGA AACAATCTCA CACGTTTGTA 1080
GGGGCACTCC CAGATGCCTG TCTCACGCTG GCACAGTCCC CGGACGGCAG GTCAGCAACA 1140
GTCACATCTC ACATCGCACA GCCAGGCATA CAGGCAAAGG GCCTAGAACT ACCCCGGCCA 1200
CAGGTCTCAG AACCAGCGGC TCACGCAGTC ACCCAATCAA GGGTCCCAGT TGCACATCCA 1260
GTCACCCCTG GACCCTGGTC ACACTGCAGA GTCACTCACA AATGGGAGTC CCGACAGACG 1320
CACAGTCCTC CCCAGACAGA GGTCAACCCA AGATGGGGGT CACACCTGAA ATCACAGTCC 1380
CCACACAATC ACGAGGTCAC ATCTGCACAC ACAGTCTCTG CACAGTCACC CTTAGGGGTC 1440
ACAACGCACA CAGTCTCCGC CTAACAGGGG TCACCCCAAG ATGGGGGTAA CCCCCTGATG 1500
TGGGTCACAG CGCACACACA GTATCCTGCA GACACTCCCA GAGGGGTCGC ACTGCATACA 1560
CAGTCCCTGC AAAGTCGCCC CCCGATAGGG GTCACACCGC ACACAAAGTC CCCGCACAGC 1620
TCCCCAAGAC AGGGTCACAT CGCACACAGT CCTCGCACGG TCACCCCGGT CCGGCTGCCC 1680
GGCTCTGTTC CTACGGCGGG GCCCCGAGGA GCCCGCGCAG CCGCCCCCCT GCCCCGCACG 1740
CGCGGCCCCA GCTCCGGCGG CCTCGGCGCG GCGTCCGGCG GCCCAGGCCG GGCGCGGCGA 1800
GCCCGGGGCT 1810